Spots Global Cancer Trial Database for START: Swiss Taxotere Alopecia Prevention Trial
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: START: Swiss Taxotere Alopecia Prevention Trial
Official Title: A Comparison of Different Scalp Cooling Systems for the Prevention of Chemotherapy Induced Alopecia
Study ID: NCT01008774
Study Description
Brief Summary: Primary objective: * Rate of complete chemotherapy induced alopecia (WHO grade III or IV, physician grading) Secondary objective: * Compliance to scalp cooling procedure * Received number of cycles of chemotherapy in each subgroup * Patient perception of scalp cooling procedure * Side effects of scalp cooling systems
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Sanofi-Aventis Administrative Office, Geneva, , Switzerland
Contact Details
Name: Clinical Sciences & Operations
Affiliation: Sanofi
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
